IBRXImmunityBio, Inc.Not started yet
Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation
HPV-Positive Oropharyngeal Squamous Cell Carcinoma · Oropharyngeal Squamous Cell Carcinoma · Head and Neck Cancer
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 70 (planned)
- Started
- Jul 22, 2026
- Main results expected
- Dec 31, 2030
- Fully finished
- Jun 27, 2031
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Progression-Free Survival (PFS)
Measured over: Up to approximately 2 years after completion of treatment
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT07628062 · record last updated 2026-06-04 · checked 2026-11-09 15:47 UTC